Safety of iliac vein stenting in the office-based laboratory: Experience with 4312 nonthrombotic iliac vein lesions
Sundeep Srivastava, Enrico Ascher, Anil Hingorani · 2026
Read Safety of iliac vein stenting in the office-based laboratory: Experience with 4312 nonthrombotic iliac vein lesions by Sundeep Srivastava, Enrico Ascher, Anil Hingorani (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13544382.txt.
Description
Sundeep Srivastava and colleagues report the safety of iliac vein stenting performed in an office-based laboratory rather than a hospital. Their 2026 analysis covers nonthrombotic iliac vein lesions, narrowings not caused by blood clots, in patients with chronic venous insufficiency.
The team reviewed 4,312 procedures in 2,642 patients treated from 2012 to 2024, all assessed with ultrasound imaging inside the vein. Patients received clopidogrel daily afterward, with no heparin during the procedure. Clotting inside the stent within 30 days was rare in every age group, from patients in their thirties to those over ninety, and did not vary meaningfully by age or disease class. Most early clots were partial rather than complete blockages. The authors present the record as evidence that office-based stenting can be done safely.
Catalog record
| CREATOR | Sundeep Srivastava, Enrico Ascher, Anil Hingorani |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |